abstract |
The inhaler has partially or completely covered internal surfaces with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers. It doses an inhalable drug composition consisting of albuterol or its physiologically acceptable salts of a fluorocarbon propellant, optionally in combination with one or more pharmacologically active substances and one or more excipients. |